ADVFN Logo
Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
Bunzl Plc NEW (PK)

Bunzl Plc NEW (PK) (BZLFF)

44.51
0.00
(0.00%)
Closed December 05 4:00PM

Professional-Grade Tools, for Individual Investors.

Key stats and details

Current Price
44.51
Bid
30.50
Ask
1,379.50
Volume
-
0.00 Day's Range 0.00
36.60 52 Week Range 48.0937
Market Cap
Previous Close
44.51
Open
-
Last Trade
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
1,026
Shares Outstanding
338,480,217
Dividend Yield
1.24%
PE Ratio
23.27
Earnings Per Share (EPS)
1.55
Revenue
11.8B
Net Profit
526.2M

About Bunzl Plc NEW (PK)

Bunzl is one of the world's fastest growing specialist distribution groups, with operations across North America, Europe and Australasia. Our business model offers significant benefits to our customers in providing outsourcing solutions and service oriented distribution which allows them to reduce o... Bunzl is one of the world's fastest growing specialist distribution groups, with operations across North America, Europe and Australasia. Our business model offers significant benefits to our customers in providing outsourcing solutions and service oriented distribution which allows them to reduce or eliminate the hidden costs of sourcing and distributing numerous goods not for resale. We source our products internationally, working with top international brands as well as local suppliers, to ensure that our customers have access to the best and most suitable products to meet their needs. By outsourcing the purchasing, consolidation and distribution of a broad range of everyday items, our customers are able to focus on their core businesses, achieve purchasing efficiencies and savings, free up working capital, improve distribution capabilities and simplify their internal administration. As a result, our customers are able to increase their efficiency and improve their competitiveness. Show more

Sector
Business Services, Nec
Industry
Paper & Paper Products-whsl
Website
Headquarters
London, Gbr
Founded
1940
Bunzl Plc NEW (PK) is listed in the Business Services sector of the OTCMarkets with ticker BZLFF. The last closing price for Bunzl (PK) was $44.51. Over the last year, Bunzl (PK) shares have traded in a share price range of $ 36.60 to $ 48.0937.

Bunzl (PK) currently has 338,480,217 shares outstanding. The market capitalization of Bunzl (PK) is $15.07 billion. Bunzl (PK) has a price to earnings ratio (PE ratio) of 23.27.

BZLFF Latest News

No news to show yet.
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10000000CS
40.4921.1177245672244.01844.5144.01868544.4201534CS
12-3.583664-7.4514264498548.09366448.09366444.018102646.91396025CS
266.0115.610389610438.548.09366436.679043.87048763CS
526.2216.244450248138.2948.09366436.6175740.26547557CS
1567.5920.557963163636.9248.09366428.86137936.96411267CS
26017.0662.149362477227.4548.09366415.21429431.19554496CS

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
TGICTriad Guaranty Inc (CE)
$ 0.001
(99,900.00%)
20.2k
KLMRKLM Royal Dutch Airlines (CE)
$ 0.0003
(29,900.00%)
454
DXFFDDunxin Financial Holdings Ltd (PK)
$ 3.95
(21,844.44%)
875
LLFLQLL Flooring Holdings Inc (CE)
$ 0.0002
(19,900.00%)
19.14k
RENORenovare Environmental Inc (CE)
$ 0.0001
(9,900.00%)
58.24k
UREQFDevex Resources Ltd (PK)
$ 0.0001
(-99.90%)
166
HLLPFHello Pal International Inc (CE)
$ 0.000001
(-99.90%)
36.6k
GLPTGlobal Profit Technologies Inc (CE)
$ 0.000001
(-99.86%)
8.6k
MOTSMotus GI Holdings Inc (CE)
$ 0.000001
(-99.75%)
464
KALRQKalera Public Ltd Company (CE)
$ 0.000001
(-99.50%)
539
HMBLHUMBL Inc (PK)
$ 0.0026
(136.36%)
2.24B
SPRVSupurva Healthcare Group Inc (PK)
$ 0.0002
(-33.33%)
459.92M
RDARRaadr Inc (PK)
$ 0.00145
(61.11%)
389.35M
CGACCode Green Apparel Corp (PK)
$ 0.0005
(-16.67%)
343.95M
THBDThird Bench Inc (PK)
$ 0.0001
(0.00%)
297.93M

Discussion

View Full Feed
LCJR LCJR 5 minutes ago
Most don't even know what XRP is, much less know the value. No rug pull here, everyone just needs patience and let it play out.

LCJR

XRPUSD
Info3 Info3 6 minutes ago
In general 
BMXI
misterfishman misterfishman 6 minutes ago
Nice day today.
RDAR
MartinLutherKing MartinLutherKing 6 minutes ago
8. TransCode Therapeutics Announces Safety Review Committee Approval of Second Cohort Opening in Phase 1 TTX-MC138 Clinical Trial Following Favorable Review of Cohort 1 Safety Data
October 23 2024 - 7:00AM

TransCode Therapeutics, Inc. (NASDAQ: RNAZ), the RNA oncology company co
RNAZ
sluggercjb sluggercjb 6 minutes ago
lol Orca has the Doc. And all shareholders running scared all those threats are keeping everyone up at night. Orca Please stop being a bully lol ..still get a good laugh at his post
VDRM
LCP77 LCP77 6 minutes ago
I meet twice a year with my tax advisor (CPA). Once about now, for year end positioning, and then for tax season. I’ve found that to be worthwhile.
NB
bananarama bananarama 8 minutes ago
Forget about a five dollar BO. After yesterday's Web Conference, that price has already jumped to at least ten dollars. If some white knight waits to buy KBLB, they will be paying twice that amount. GO KBLB!
KBLB
nt2innovate nt2innovate 8 minutes ago
Yes. Good call. Hopefully buying will increase on the OTC with retail and family offices if they start seeing 30-40% annual growth rates going forward without dilution as you said which will cause the stock price to go up significantly.

The idea of the PEC along with Enclave having va
SDCH
northam43 northam43 8 minutes ago
Report # 6.1 SPX Cycles Short Range Chart (60 min & Daily Cycles)

https://investorshub.advfn.com/uimage/uploads/2024/12/5/stiec6.1_Short_Term.png
jsc52033 jsc52033 8 minutes ago
actualy its down 3,397 from yesterday yet yes way ahead of Tueday which was almost none at 150,000 +
BMXI
MartinLutherKing MartinLutherKing 9 minutes ago
6.TransCode Therapeutics Announces First Patients Treated in Phase 1 Clinical Trial with First-in-Class Lead Therapeutic Candidate
September 17 2024 - 7:00AM

TransCode Therapeutics, Inc. (NASDAQ: RNAZ), the RNA oncology company committed to more effectively treating cancer usin
RNAZ
fwb fwb 10 minutes ago
If it's McDonald NEWS, we could go higher than $20.00
SOUN
XenaLives XenaLives 10 minutes ago
Define "e" as massive AI manipulation of the market as a whole....
AVXL
band aid band aid 10 minutes ago
Does anyone think they will figure out how to sell a few more trinkets then they have in the past. I guess we shall see in the once a year financial reports. Then maybe the company may have a couple of bucks in the bank.
BIEL
northam43 northam43 10 minutes ago
Report # 6.1 SPX Cycles Short Range Chart (60 min & Daily Cycles)

https://investorshub.advfn.com/uimage/uploads/2024/12/5/stiec6.1_Short_Term.png
zab zab 10 minutes ago
The trump clown show is in full display for everyone to see, another reason only 49 percent of America voted for orange shittypants.  But remember trump will blame everyone else for his daily mistakes,  and meltdowns.
MartinLutherKing MartinLutherKing 10 minutes ago
5.TransCode Therapeutics Announces Publication of Study with Lead Therapeutic Candidate Revealing Mechanisms Behind Candidate’s Preclinical Efficacy Against Metastatic Cancer
September 10 2024 - 7:00AM


TransCode Therapeutics, Inc. (NASDAQ: RNAZ), the RNA oncology compan
RNAZ
misterfishman misterfishman 10 minutes ago
There is plenty of frustration going on over here mostly due to impatience peeps this stock is a longterm play like a few years out if peeps can't wait then sell.its that simple.
IGPK
bananarama bananarama 11 minutes ago
I totally agree with you, Monkey! Any company interested in buying KBLB would recognize that it is better to buy the company now rather than wait for it to reach the Texas Exchange (or the NASDQ). Then, the BO price will be MUCH MUCH higher. GO KBLB! ;-)
KBLB
MartinLutherKing MartinLutherKing 11 minutes ago
4.TransCode Therapeutics Awarded $2 Million NIH Grant to Support Clinical Evaluation of Lead Candidate
September 05 2024 - 7:00AM

TransCode Therapeutics, Inc. (NASDAQ: RNAZ), the RNA oncology company committed to more effectively treating cancer using RNA therapeutics, today an
RNAZ

Your Recent History

Delayed Upgrade Clock